$1.39
-2.56-64.81%
Últ. Act.: Oct 23, 7:59 PM
Aardvark Therapeutics (AARD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.88 | $-0.89 | $-0.82 | $-0.81 |
| Actual | $-0.66 | $-0.99 | $-0.81 | $-0.75 |
| Surprise | +25.0% | -11.2% | +1.22% | +7.41% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | — | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.70 | $-0.68 | $-0.58 | $-0.58 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.66 | $-0.88 | 25.0 % |
| Q1 | May 7, 2026 | $-0.99 | $-0.89 | -11.2 % |
| Q4 | Mar 23, 2026 | $-0.81 | $-0.82 | 1.22 % |
| Q3 | Nov 13, 2025 | $-0.75 | $-0.81 | 7.41 % |